APGE
Price
$33.11
Change
+$1.07 (+3.34%)
Updated
Apr 17 closing price
Capitalization
1.92B
31 days until earnings call
SPRY
Price
$14.88
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
1.46B
30 days until earnings call
Ad is loading...

APGE vs SPRY

Header iconAPGE vs SPRY Comparison
Open Charts APGE vs SPRYBanner chart's image
Apogee Therapeutics
Price$33.11
Change+$1.07 (+3.34%)
Volume$347.97K
Capitalization1.92B
ARS Pharmaceuticals
Price$14.88
Change-$0.00 (-0.00%)
Volume$1.55M
Capitalization1.46B
APGE vs SPRY Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. SPRY commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and SPRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (APGE: $33.11 vs. SPRY: $14.88)
Brand notoriety: APGE and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 47% vs. SPRY: 87%
Market capitalization -- APGE: $1.92B vs. SPRY: $1.46B
APGE [@Biotechnology] is valued at $1.92B. SPRY’s [@Biotechnology] market capitalization is $1.46B. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRY is a better buy in the long-term than APGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 6 bearish.
  • SPRY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SPRY is a better buy in the short-term than APGE.

Price Growth

APGE (@Biotechnology) experienced а +10.59% price change this week, while SPRY (@Biotechnology) price change was +12.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

SPRY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($1.92B) has a higher market cap than SPRY($1.46B). SPRY YTD gains are higher at: 41.043 vs. APGE (-26.909). SPRY has higher annual earnings (EBITDA): -60.51M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. SPRY (205M). SPRY has less debt than APGE: SPRY (102K) vs APGE (11.8M). SPRY has higher revenues than APGE: SPRY (2.57M) vs APGE (0).
APGESPRYAPGE / SPRY
Capitalization1.92B1.46B132%
EBITDA-216.68M-60.51M358%
Gain YTD-26.90941.043-66%
P/E RatioN/A186.00-
Revenue02.57M-
Total Cash521M205M254%
Total Debt11.8M102K11,569%
TECHNICAL ANALYSIS
Technical Analysis
APGESPRY
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
79%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 5 days ago
90%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PUVCX40.43N/A
N/A
Putnam International Capital Opp C
VSGIX66.19N/A
N/A
Vanguard Small Cap Growth Index I
NBHRX13.45N/A
N/A
Neuberger Berman Equity Income R3
FAZYX13.24N/A
N/A
Fidelity Advisor Multi-Asset Income M
CETAX12.55N/A
N/A
Centerstone Investors A